Prodotto aggiunto correttamente al carrello.

discount label
H-SLLMWITQA-OH
Visualizzare in 3D

Biosynth logo

H-SLLMWITQA-OH

Rif. 3D-PP48511

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-SLLMWITQA-OH
Descrizione:

Peptide H-SLLMWITQA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLLMWITQA-OH include the following: Yeast-based vaccine approaches to cancer immunotherapy SW Howland - 2008 - dspace.mit.eduhttps://dspace.mit.edu/handle/1721.1/45949 Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination Q Chen , H Jackson, M Shackleton , P Parente - Cancer Immunity, 2005 - AACRhttps://aacrjournals.org/cancerimmun/article-abstract/5/1/5/471995 The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed beta2-Microglobulin through Distinct Binding Sites PS Merkle, M Irving , S Hongjian, M Ferber - Biochemistry, 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biochem.7b00385 Ex vivo Detectable Human CD8 T-Cell Responses to Cancer-Testis Antigens P Baumgaertner, N Rufer, E Devevre, L Derre - Cancer research, 2006 - AACRhttps://aacrjournals.org/cancerres/article-abstract/66/4/1912/526674 Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell M Irving , V Zoete, M Hebeisen, D Schmid - Journal of Biological , 2012 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)43479-9/abstract Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells M Hebeisen, J Schmidt, P Guillaume, P Baumgaertner - Cancer research, 2015 - AACRhttps://aacrjournals.org/cancerres/article-abstract/75/10/1983/599934 In vivo persistence of codominant human CD8+ T cell clonotypes is not limited by replicative senescence or functional alteration L Derre, M Bruyninx, P Baumgaertner - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/179/4/2368/37815 Naturally Acquired MAGE-A10-and JC Cerottini, DE Speiser , H Chaubert, P Romero - J Immunol, 2005 - academia.eduhttps://www.academia.edu/download/42028213/1709.pdf Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide® ISA-51: association with survival J Karbach, S Gnjatic, A Bender - journal of cancer, 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.24850 Naturally acquired MAGE-A10-and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma G Bricard, H Bouzourene, O Martinet - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/3/1709/72401 Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function DA Schmid, MB Irving , V Posevitz - The Journal of , 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/9/4936/83386 Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8+ T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients D Valmori, V Dutoit , D Liénard, D Rimoldi, MJ Pittet - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/16/4499/506558 T cell inflammation profile after surgical resection may predict tumor recurrence in HBV-related hepatocellular carcinoma B Song, S Zhen, F Meng - International immunopharmacology, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1567576916304209 Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes AK Bentzen , AM Marquard , R Lyngaa, SK Saini - Nature , 2016 - nature.comhttps://www.nature.com/articles/nbt.3662 Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma AJ Gehring , ZZ Ho, AT Tan , MO Aung, KH Lee, KC Tan - Gastroenterology, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0016508509005587

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP48511 H-SLLMWITQA-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".